- Aimed Bio has received approval for a KOSDAQ IPO from the Korea Exchange.
- The company plans to proceed with the next steps of the IPO process, including submission of the securities registration statement and commencement of the public offering process.
- The approval is seen as further validation of AimedBio’s technological capability and growth potential.
